12/22
09:43 am
iclr
Clinical Trial Supply & Logistics Market Outlook, 2025-2032 - A 48 Billion-Dollar Opportunity Featuring Strategic Insights Into 43 Key Companies [Yahoo! Finance]
Low
Report
Clinical Trial Supply & Logistics Market Outlook, 2025-2032 - A 48 Billion-Dollar Opportunity Featuring Strategic Insights Into 43 Key Companies [Yahoo! Finance]
12/17
09:02 am
iclr
Here's Why ICON Plc. (ICLR) Gained +20.3% in Q3 [Yahoo! Finance]
Low
Report
Here's Why ICON Plc. (ICLR) Gained +20.3% in Q3 [Yahoo! Finance]
12/16
04:37 pm
iclr
Icon (NASDAQ:ICLR) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Icon (NASDAQ:ICLR) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
12/15
10:08 am
iclr
Icon (NASDAQ:ICLR) was downgraded by analysts at Bank of America Corporation from a "buy" rating to a "neutral" rating. They now have a $195.00 price target on the stock.
Low
Report
Icon (NASDAQ:ICLR) was downgraded by analysts at Bank of America Corporation from a "buy" rating to a "neutral" rating. They now have a $195.00 price target on the stock.
12/15
07:19 am
iclr
Icon (NASDAQ:ICLR) was given a new $200.00 price target on by analysts at Barclays PLC.
Low
Report
Icon (NASDAQ:ICLR) was given a new $200.00 price target on by analysts at Barclays PLC.
12/10
10:39 am
iclr
BMO Capital Maintains Outlook On ICON Public Limited Company (ICLR) After Management Call [Yahoo! Finance]
Low
Report
BMO Capital Maintains Outlook On ICON Public Limited Company (ICLR) After Management Call [Yahoo! Finance]
12/9
07:15 am
iclr
ICON 2025 global biotech survey solidifies China dominance and highlights opportunities for Western biotechs to stay competitive
Low
Report
ICON 2025 global biotech survey solidifies China dominance and highlights opportunities for Western biotechs to stay competitive
12/2
07:15 am
iclr
ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions
Low
Report
ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions
11/27
06:18 am
iclr
Icon (NASDAQ:ICLR) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Low
Report
Icon (NASDAQ:ICLR) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
11/26
02:09 pm
iclr
Icon (NASDAQ:ICLR) had its "hold (c-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Icon (NASDAQ:ICLR) had its "hold (c-)" rating reaffirmed by analysts at
Weiss Ratings.
11/24
08:32 pm
iclr
FMI Global Equity Q3 2025 Commentary [Seeking Alpha]
Medium
Report
FMI Global Equity Q3 2025 Commentary [Seeking Alpha]
11/21
07:04 pm
iclr
Icon PLC (ICLR) Down 12.2% Since Last Earnings Report: Can It Rebound? [Yahoo! Finance]
Low
Report
Icon PLC (ICLR) Down 12.2% Since Last Earnings Report: Can It Rebound? [Yahoo! Finance]
11/14
04:43 pm
iclr
ICON Public Limited Company (ICLR) Soared on Robust Performance [Yahoo! Finance]
Medium
Report
ICON Public Limited Company (ICLR) Soared on Robust Performance [Yahoo! Finance]
11/13
08:11 am
iclr
Icon (NASDAQ:ICLR) is now covered by analysts at BMO Capital Markets. They set a "market perform" rating and a $175.00 price target on the stock.
Low
Report
Icon (NASDAQ:ICLR) is now covered by analysts at BMO Capital Markets. They set a "market perform" rating and a $175.00 price target on the stock.
11/12
07:13 am
iclr
ICON plc to Present at the Jefferies London Healthcare Conference [Yahoo! Finance]
Neutral
Report
ICON plc to Present at the Jefferies London Healthcare Conference [Yahoo! Finance]
11/12
06:45 am
iclr
ICON plc to Present at the Jefferies London Healthcare Conference
Neutral
Report
ICON plc to Present at the Jefferies London Healthcare Conference
10/24
12:57 pm
iclr
Icon (NASDAQ:ICLR) had its price target lowered by analysts at TD Cowen from $183.00 to $172.00. They now have a "hold" rating on the stock.
Low
Report
Icon (NASDAQ:ICLR) had its price target lowered by analysts at TD Cowen from $183.00 to $172.00. They now have a "hold" rating on the stock.
10/24
10:12 am
iclr
Icon (NASDAQ:ICLR) had its "hold" rating reaffirmed by analysts at Cowen Inc.
Low
Report
Icon (NASDAQ:ICLR) had its "hold" rating reaffirmed by analysts at Cowen Inc.
10/24
10:11 am
iclr
Icon (NASDAQ:ICLR) was given a new $220.00 price target on by analysts at Robert W. Baird.
Low
Report
Icon (NASDAQ:ICLR) was given a new $220.00 price target on by analysts at Robert W. Baird.
10/24
10:11 am
iclr
Icon (NASDAQ:ICLR) was given a new $220.00 price target on by analysts at UBS Group AG.
Low
Report
Icon (NASDAQ:ICLR) was given a new $220.00 price target on by analysts at UBS Group AG.
10/24
10:05 am
iclr
Icon (NASDAQ:ICLR) had its price target lowered by analysts at Barclays PLC from $190.00 to $185.00. They now have an "equal weight" rating on the stock.
Low
Report
Icon (NASDAQ:ICLR) had its price target lowered by analysts at Barclays PLC from $190.00 to $185.00. They now have an "equal weight" rating on the stock.
10/23
07:00 pm
iclr
Icon (NASDAQ:ICLR) was given a new $220.00 price target on by analysts at Leerink Partners.
Low
Report
Icon (NASDAQ:ICLR) was given a new $220.00 price target on by analysts at Leerink Partners.
10/22
04:46 pm
iclr
ICON Reports Third Quarter 2025 Results [Yahoo! Finance]
Low
Report
ICON Reports Third Quarter 2025 Results [Yahoo! Finance]
10/22
04:25 pm
iclr
ICON Reports Third Quarter 2025 Results
Medium
Report
ICON Reports Third Quarter 2025 Results
10/8
12:25 pm
iclr
Icon (NASDAQ:ICLR) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Icon (NASDAQ:ICLR) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.